1,25-Dihydroxyvitamin D3 and Prostaglandin E2 Act Directly on Circulating Human Osteoclast Precursors

This publication has 32 references indexed in Scilit:

• Human osteoblasts support human monocyte-osteoclast differentiation: evidence of prostaglandin stimulation
  Bone, 1999
• Reciprocal Gene Expression of Osteoclastogenesis Inhibitory Factor and Osteoclast Differentiation Factor Regulates Osteoclast Formation
  Biochemical and Biophysical Research Communications, 1999
• RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
  Biochemical and Biophysical Research Communications, 1998
• A Combination of Osteoclast Differentiation Factor and Macrophage-Colony Stimulating Factor Is Sufficient for both Human and Mouse Osteoclast Formation in Vitro
  Endocrinology, 1998
• Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures
  Biochemical and Biophysical Research Communications, 1998
• Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of Bone
  Biochemical and Biophysical Research Communications, 1998
• Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
  Cell, 1998
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
  Proceedings of the National Academy of Sciences, 1998
• The human osteoclast precursor circulates in the monocyte fraction.
  Endocrinology, 1996
• Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.
  Proceedings of the National Academy of Sciences, 1990